Midas Pharma

Executive Summary

Midas Pharma is a German pharmaceutical services and supply company founded in 2005 and headquartered in Ingelheim. It operates as an integrated partner across the entire pharmaceutical value chain, offering a broad portfolio of products ranging from starting materials to finished dosage forms, as well as comprehensive services including contract development, manufacturing, and supply chain management. The company serves both small molecule and biopharmaceutical sectors, positioning itself as a one-stop shop for pharma companies seeking to outsource non-core activities. By providing end-to-end solutions, Midas Pharma helps clients reduce time-to-market and optimize costs, leveraging its expertise in drug delivery and small molecules. As a privately held company, Midas Pharma is not publicly traded, but it plays a crucial role in the pharmaceutical ecosystem. Its integrated service model and focus on quality and reliability make it a trusted partner for many drug developers. While the company does not have its own drug pipeline, its growth is tied to the increasing trend of pharmaceutical outsourcing. With a strong foundation in Germany and potential for international expansion, Midas Pharma is well-positioned to benefit from the growing demand for contract development and manufacturing services. The company's steady revenue streams and diversified client base contribute to its resilience in the market.

Upcoming Catalysts (preview)

• TBDExpansion of manufacturing capacity or service offerings70% success